Anti‐adipogenic regulation underlies hepatic stellate cell transdifferentiation
- 22 August 2006
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (s3) , S102-S105
Abstract
Cirrhosis is the most important consequence of alcoholic liver disease for which liver transplantation is the only treatment option available. Transdifferentiation of hepatic stellate cells (HSC) to myofibroblastic cells (MF) is a central event in liver fibrogenesis, and understanding molecular mechanisms that underlie this cellular event provides pivotal insights into development of new therapeutic modalities for cirrhosis. To this end, the authors proposed several years ago that transdifferentiation of quiescent HSC to MF may be causally associated with transcriptional regulation known for adipocyte–preadipocytic fibroblast dedifferentiation. In support of this notion, the authors showed that adipogenic transcription factors and their downstream adipocyte specific genes are expressed abundantly in quiescent HSC and that this expression profile is lost in HM. Further, gain‐of‐function manipulations for adipogenic transcription factors such as peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) and sterol regulatory element binding protein‐1c have been shown to reverse culture‐induced MF to quiescent HSC. The authors also demonstrated that tumor necrosis factor‐α and Wnt, known mediators of anti‐adipogenesis, also suppress the activity of PPAR‐γ and contribute to HSC‐MF transdifferentiation. These results reinforce the concept of adipogenic regulation essential to the quiescent phenotype and the loss of such regulation underlying HSC‐HM transdifferentiation. They also provide insights into the molecular basis for the use of PPAR‐γ agonists, which has been advocated for treatment of liver fibrosis.Keywords
This publication has 34 references indexed in Scilit:
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Cytokine Receptors and Signaling in Hepatic Stellate CellsSeminars in Liver Disease, 2001
- Inhibition of Adipogenesis by Wnt SignalingScience, 2000
- Hepatic Stellate Cells Express the Low Affinity Nerve Growth Factor Receptor p75 and Undergo Apoptosis in Response to Nerve Growth Factor StimulationThe American Journal of Pathology, 2000
- Tumor necrosis factor alpha (TNFα) and transforming growth factor β1 (TGFβ1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblastsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1993
- Differential effects of interleukin‐1α, tumor necrosis factor α, and transforming growth factor β1 on cell proliferation and collagen formation by cultured fat‐storing cellsLiver International, 1989
- Immunocytochemical Detection of Desmin in Fat-Storing Cells (Ito Cells)Hepatology, 1984
- Über den Einfluß des Futters auf die Fettspeicherungszellen der KaninchenleberArchivum histologicum japonicum, 1954
- Über den Einfluß der Insulin-Traubenzucker-Injektion auf die “Fettspeicherungszellen” der LeberArchivum histologicum japonicum, 1952